Unusual thyroiditis after recombinant interleukin-2 therapy.
Abad
S
S
Service de Médecine Interne 2, St-Vincent de Paul, Université René Descartes, 27 rue du Faubourg St-Jacques 75679 Paris, Cedex 14, France. sebastian.abad@cch.ap-hop-paris.fr
Blanche
P
P
Moachon
L
L
Brunet
A
A
Héripret-Fredouille
L
L
Sicard
D
D
Salmon-Céron
D
D
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000328:Adult; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D013968:Thyroiditis, Subacute / Q000139:chemically induced*
D000276:Adjuvants, Immunologic; D007376:Interleukin-2